lidocaine / methyl salicylate / zinc oxide

RxCUI
1008426
RxNorm name
lidocaine / methyl salicylate / zinc oxide
Term type
MIN
Status
Active
Updated
2026-06-11 07:00:56

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
092010
Active start
092010
Multiple ingredient
YES
Branded
NO

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
zinc oxide11423
methyl salicylate29787
lidocaine6387

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
RXNAV_STRlidocaine / methyl salicylate / zinc oxideNAMES
RxNorm Namelidocaine / methyl salicylate / zinc oxideNAMES
TTYMINATTRIBUTES
RxCUI1008426CODES

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN01BBAmidesATC1-4lidocaine
ATCS02DAAnalgesics and anestheticsATC1-4lidocaine
ATCD04ABAnesthetics for topical useATC1-4lidocaine
ATCR02ADAnesthetics, localATC1-4lidocaine
ATCC01BBAntiarrhythmics, class IbATC1-4lidocaine
ATCS01HALocal anestheticsATC1-4lidocaine
ATCC05ADLocal anestheticsATC1-4lidocaine
FDASPLN0000175682Amide Local AnestheticEPChas_epclidocaine
FDASPLN0000175426AntiarrhythmicEPChas_epclidocaine
FDASPLN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine
MEDRTD012459SalicylatesCHEMhas_ingredientmethyl salicylate
MEDRTD015034Zinc OxideCHEMhas_ingredientzinc oxide
MEDRTD059787Acute PainDISEASEmay_treatmethyl salicylate
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine
MEDRTD001168ArthritisDISEASEmay_treatmethyl salicylate
MEDRTD001416Back PainDISEASEmay_treatmethyl salicylate
MEDRTD002056BurnsDISEASEmay_treatlidocaine
MEDRTD019080Cafe-au-Lait SpotsDISEASEmay_preventzinc oxide
MEDRTD003288ContusionsDISEASEmay_treatmethyl salicylate
MEDRTD003876Dermatitis, AtopicDISEASEmay_treatzinc oxide
MEDRTD003963Diaper RashDISEASEmay_treatzinc oxide
MEDRTD004342Drug HypersensitivityDISEASEci_withmethyl salicylate
MEDRTD004342Drug HypersensitivityDISEASEci_withzinc oxide
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine
MEDRTD004485EczemaDISEASEmay_treatzinc oxide
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine
MEDRTD006967HypersensitivityDISEASEci_withlidocaine
MEDRTD007249InflammationDISEASEmay_treatmethyl salicylate
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine
MEDRTD009120Muscle CrampDISEASEmay_treatmethyl salicylate
MEDRTD010146PainDISEASEmay_preventlidocaine
MEDRTD010146PainDISEASEmay_treatlidocaine
MEDRTD012878Skin NeoplasmsDISEASEmay_preventzinc oxide
MEDRTD013180Sprains and StrainsDISEASEmay_treatmethyl salicylate
MEDRTD013471SunburnDISEASEmay_preventzinc oxide
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine
MEDRTD014947Wounds and InjuriesDISEASEmay_treatzinc oxide
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moamethyl salicylate
MEDRTN0000000065Physiochemical ActivityMOAhas_moazinc oxide
MEDRTN0000000108Prostaglandin Receptor AntagonistsMOAhas_moamethyl salicylate
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_pemethyl salicylate
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000009006Decreased Thromboxane ProductionPEhas_pemethyl salicylate
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTN0000009881Sunscreening ActivityPEhas_pezinc oxide

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESTTYMIN
CODESRxCUI1008426
NAMESRXNAV_STRlidocaine / methyl salicylate / zinc oxide
NAMESRxNorm Namelidocaine / methyl salicylate / zinc oxide